These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30257336)

  • 21. Antibiotic resistance mechanisms in M. tuberculosis: an update.
    Nguyen L
    Arch Toxicol; 2016 Jul; 90(7):1585-604. PubMed ID: 27161440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired drug resistance during inadequate therapy in a young child with tuberculosis.
    Garcia-Prats AJ; Willemse M; Seifart HI; Jordaan AM; Werely CJ; Donald PR; Schaaf HS
    Pediatr Infect Dis J; 2014 Aug; 33(8):883-5. PubMed ID: 25222312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting iron acquisition by Mycobacterium tuberculosis.
    Monfeli RR; Beeson C
    Infect Disord Drug Targets; 2007 Sep; 7(3):213-20. PubMed ID: 17897057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.
    Ho J; Jelfs P; Sintchencko V
    J Antimicrob Chemother; 2013 Dec; 68(12):2915-20. PubMed ID: 23838950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of primary drug resistance of Mycobacterium tuberculosis from two hospitals in Tenerife, Canary Islands, Spain (1990-1997).
    Lecuona M; Alvarez R; Quintero J; Torres A; Hernández AM; Montesinos I; Sierra A
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):186-7. PubMed ID: 10694101
    [No Abstract]   [Full Text] [Related]  

  • 26. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.
    Rattan A; Kalia A; Ahmad N
    Emerg Infect Dis; 1998; 4(2):195-209. PubMed ID: 9621190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
    Achar J; Berry C; Herboczek K; Parpieva N; Tillyashaykhov MN; Tigay ZN; Khamraev A; Velivela K; Seddon JA; du Cros P
    Emerg Infect Dis; 2015 Nov; 21(11):2105-6. PubMed ID: 26488556
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for
    Catanzaro DG; Trollip AP; Seifert M; Georghiou SB; Garfein RS; Rodwell TC; Catanzaro A; Eisenach KD
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28381434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
    Mokrousov I
    Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
    [No Abstract]   [Full Text] [Related]  

  • 31. Pyrazinamide resistance among drug-resistant Mycobacterium tuberculosis isolates at a referral hospital.
    Arora J; Sidiq Z; Visalakshi P; Bhalla M; Behera D; Myneedu VP
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):380-1. PubMed ID: 24075630
    [No Abstract]   [Full Text] [Related]  

  • 32. Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis.
    Sotgiu G; Tiberi S; D'Ambrosio L; Centis R; Alffenaar JW; Caminero JA; Abdo Arbex M; Alarcon Guizado V; Aleksa A; Dore S; Gaga M; Gualano G; Kunst H; Payen MC; Roby Arias AJ; Skrahina A; Solovic I; Sulis G; Tadolini M; Zumla A; Migliori GB;
    Eur Respir J; 2016 Nov; 48(5):1503-1507. PubMed ID: 27587544
    [No Abstract]   [Full Text] [Related]  

  • 33. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
    Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
    Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multidrug-resistant tuberculosis].
    Mori T
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):192-4. PubMed ID: 10088371
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis.
    Young EF; Perkowski E; Malik S; Hayden JD; Durham PG; Zhong L; Welch JT; Braunstein MS; Hickey AJ
    Pharm Res; 2016 Oct; 33(10):2495-505. PubMed ID: 27351427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
    Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibiotic drug-resistant tuberculosis].
    Greinert U; Hillemann D; Lange C; Richter E
    Med Klin (Munich); 2007 Dec; 102(12):957-66. PubMed ID: 18075716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium tuberculosis "Beijing" epidemics: a race against mutations?
    Bhatter P; Chatterjee A; Mistry N
    Tuberculosis (Edinb); 2012 Jan; 92(1):92-4. PubMed ID: 22015174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early Biomarkers and Regulatory Innovation in Multidrug-Resistant Tuberculosis.
    Wallis RS; Peppard T
    Clin Infect Dis; 2015 Oct; 61Suppl 3():S160-3. PubMed ID: 26409278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.